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Abstract
Background: The prevalence of foot ulcers in patients with rheumatoid arthritis (RA) has been reported at
almost 10 %. These foot ulcers often occur at multiple sites and are reoccurring, with the potential risk of
infection increased due to RA diagnosis and disease modifying medications. The objective of this study was
to estimate the prevalence of clinical infection in foot-ulcers of patients with RA; describe the microbiological
characteristics and investigate risk factors.
Methods: Retrospective clinical data was collected for all patients attending a rheumatology foot ulcer clinic
between 1st May 2012 and 1st May 2013: wound swab data was collected from those with clinical infection.
Results: Twenty-eight patients with RA and foot-ulcers were identified; eight of these patients had clinical
infection and wound swabs taken (29 %).
Of these eight patients there were equal men and women, with median age 74 years, and average disease duration
22 years.
Cardiovascular disease/peripheral-vascular disease (CVD/PVD) were reported in six patients, diabetes in two patients.
Six patients were treated with disease-modifying anti-rheumatic drugs (DMARDs); three were on biologic medications
and two on steroids.
Five wound swabs cultured skin flora, one staphylococcus aureus, one had no growth after culture; and one was
rejected due to labelling error.
Conclusion: Almost a third of people with RA and foot ulcers attending clinic over one year had clinical infection,
however microbiological analysis failed to isolate pathogens in six of seven wound swabs. This may be due to
inaccurate diagnosis of ulcer infection or to issues with sampling, collection, transport, analysis or reporting. There was
insufficient data to relate risk of clinical infection with risk factors.
Further research is required to identify the most appropriate techniques for infection diagnosis, wound sampling and
processing.
Trial registration: Ethical approval was obtained from University of Leeds, Faculty of Medicine and Health
(Reference number: SHREC/RP/349).
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Background
Between 50 and 93 % of patients with RA will have foot
and ankle symptoms during the course of their disease;
these have a marked impact on quality of life and mobil-
ity [1–3]. Persistent synovitis in the foot is associated
with periarticular erosions and deformity throughout the
foot [1] possibly leading to difficulty accommodating
footwear and increasing plantar pressure [4]. Over time
foot deformity and trauma from footwear can increase
the risks of damage to surrounding skin, resulting in loss
of skin integrity which may lead to foot-ulcers [5]. A
foot-ulcer is defined as a skin defect including both the
epidermis and the dermis, occurring in isolation on or
below the midline of the malleoli and requiring ≥14 days
to heal [6, 7].
The prevalence of foot-ulcers found in a self-report
postal study of RA patients in Bradford, West Yorkshire
was almost 10 %, however if patients with coexisting dia-
betes were excluded this would change to 3.13 % [5].
These foot-ulcers of patients with RA often occur at
multiple sites and almost 50 % of patients suffer from re-
current ulcers [5, 7]. Although ulcers are usually small
healing is slow, which increases the potential for infec-
tion [7]. Due to the increased risk of developing skin
and soft tissue infections in patients with RA [8] mini-
mising potential risk should be a priority for practi-
tioners. Being able to identify an infected foot-ulcer is
essential to provide appropriate care, including decisions
on continuation of immunosuppressive and immune-
modulating medications. Clinical diagnosis of infection
is determined through signs and symptoms and reliant
on the experience of individual practitioners [9],
although the validity of such a tool has yet to be proven
in RA patients. Wound infection is defined as multiple
bacteria present which can cause damage to wound tis-
sue and delay healing [10]. Following a diagnosis of clin-
ical infection, identification of micro-organisms using a
swab, or tissue sample, allows for targeted treatment and
appropriate use of antibiotics, which is essential to re-
duce the incidence of bacterial resistance [11]. In the au-
thors experience microbiology reports typically take
several days to reach the clinician so selection of first
line, empirical, antibiotic therapy is based on prior
knowledge of likely infective organisms in the specific
clinical population.
Despite the known burden of foot ulcers in RA [6]
there remain large gaps in knowledge of the sequelae
and treatment of this population. The prevalence and
microbiological characteristics of infected foot-ulcers
have not previously been identified so there is a lack of
information to guide first line antibiotic selection in pa-
tients with RA.
The primary aim of the study was to identify the
prevalence of clinically infected foot-ulcers in patients
diagnosed with RA, who attended a foot ulcer clinic of a
large teaching hospital and subsequently identify and quan-
tify the types of microorganisms found in those ulcers.
The secondary aim of the study was to identify rela-
tionships between the types of microorganisms identified
in the ulcer and previously identified risk factors for in-
fection in patients with RA.
Methods
This descriptive epidemiological study identified the
number of RA patients with clinically infected foot ul-
cers. The microorganisms were identified and quantified
through microscopy culture results.
Retrospective data was obtained from clinic notes and
electronic records of all patients attending the weekly
rheumatology foot-ulcer clinic in a large NHS teaching
hospital Trust between 1st May 2012 and 1st May 2013;
this determined the population size [Fig. 1].
All patients with a consultant diagnosis of RA who
presented with an active foot-ulcer and had a wound
swab taken between 1st May 2012 and 1st May 2013
became the main focus of the study [swab group]. If
multiple wound swabs were taken, the first taken in the
study period was identified as the index swab. All micro-
biology reports were collected from 12 months prior to
the index swab date and the three months after. This
15 month review of microbiology reports allowed the
researchers to capture the reoccurring nature of foot-
ulcers and infection. Due to time constraints the major-
ity of data was retrospective, pre-dating the index swab.
Wound swabs taken above the midline of the malleoli
were excluded.
The patients who had RA and foot ulcers but no
swabs taken became the comparison group and had
minimal data collected from their first clinic attendance
during the study period. This enabled comparisons of
age, gender and disease duration to be made between
the two groups.
The dependent variables investigated were the micro-
biological characteristics identified from swab results ob-
tained from the foot ulcers of the RA patients in the
study.
The independent variables included the possible con-
tributory factors, other than RA, as the causation of the
foot-ulcer infection, these included: Demographic data,
current medications, disease activity scores (DAS 28)
[12], comorbidities of diabetes, connective tissue dis-
ease, cardiovascular / peripheral vascular disease (these
terms include myocardial infusion [MI] Cerebrovascular
accidents [CVA] Transient ischaemic attack [TIA].) and
smoking habits.
Gender details were collected to see if the 3:1 (Female:
Male) incidence of developing RA and foot-ulcers [7, 13]
are reflected in the numbers developing infection.
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Immunosuppressant and steroid medications used
to treat RA, can increase the risk of infection by their
very action of dampening the autoimmune response.
With anti-TNF therapies being linked to an increase
in skin and soft tissue infections [14–16].
RA disease activity (reflected in the DAS 28 score)
[12] has been linked to infection with an increased
risk of infection seen in patients with higher DAS 28
scores [17, 18].
Diabetes is known to be a major risk factor for the de-
velopment of foot ulcers [19, 20] and this together with
delayed healing, increased infection risk, neuropathy and
peripheral vascular disease all contribute to a higher risk
of infection in the foot ulcers [21–23].
Connective tissue diseases (CTD) are often associated
with self-reported foot problems [24] particularly when
conditions affect the circulation and/or peripheral sensa-
tion [25].
Cardiovascular/Peripheral-vascular Disease (CVD/PVD)
can cause decreased blood flow to the foot ulcer resulting
in depleted oxygen supply so creating hypoxia within the
wound. Although hypoxia can stimulate wound healing
and angiogenesis initially, sustained hypoxia prevents
the supply of oxygen and nutrients needed for wound
healing [26, 27].
Smoking cigarettes has been shown to delay wound
healing [28, 29] and diabetic patients with foot ulcers
who smoke are more likely to require amputation than
non-smokers [30]. In RA patients smoking cigarettes has
been linked with increased disease activity [31–33] and
the development of rheumatoid nodules [34].
Descriptive statistical analysis of individual variables
allowed central tendencies to be displayed.
Ethical approval was obtained from University of
Leeds, Faculty of Medicine and Health (Reference num-
ber: SHREC/RP/349).
Fig. 1 Flow Chart. Flow Chart to identify the eight patients with RA included in the analysis
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Results
Fifty-seven patients attended the rheumatology foot-
ulcer clinic during the study period, 31 of whom had a
diagnosis of RA. Twenty eight of the 31 patients with
RA had foot-ulcers and eight of those patients had
wound swabs taken during the study period (Fig. 1).
Therefore 28.5 % were considered to have clinical
infection in their foot ulcers. One swab was rejected
by the microbiology laboratory due to incomplete
labelling.
Table 1 displays demographic data, current medica-
tions, DAS 28 and comorbidities for the eight patients.
DAS 28 was not documented within 4 weeks of the
index swab date for any of the eight patients (Table 1).
The characteristics of the twenty patients with RA and
foot-ulcer/s who had no wound swabs taken between 1st
May 2012 and 1st May 2013 (comparison group) are in
Table 2.
The microbiological profile (Table 3) was obtained
from the swabs of the eight study patients. Seven of the
patients had swabs taken from the toes and one was
from the foot. The microbiology report provided the mi-
croscopy culture information (Table 3) for seven viable
wound swabs. The swab results reported skin flora in
five patients, one in conjunction with enteric flora (one
toe swab) and three in conjunction with anaerobes.
Staphylococcus aureus was isolated in one patient. No
growth was reported in one swab.
Sensitivities identified by microbiology are reported in
Table 3.
Only one patient was treated with the antibiotics iden-
tified in the microbiology report (Table 3 study no.6).
Four patients were treated with antibiotics not specified
as sensitive.
Discussion
This is the first study to describe the prevalence of clin-
ical infection in RA foot-ulcers and the microbiological
characteristics of infections.
Heavy growth of one/mixed bacteria can disrupt heal-
ing and cause damage to wound tissue, typically seen in
wound infections [10]. Only one of the seven swab
results demonstrated this trait. This may be because des-
pite clinical appearance there was no infection, or that
sampling failed to collect and grow live organisms.
Swabbing technique, the ability of the micro-organisms
to survive in transit to the laboratory and the procedures
within the laboratories [35, 36] all contribute towards
the performance of swabbing as a way to identify organ-
isms within a wound.
The skin is naturally colonised by many microorgan-
isms, most of which are harmless to the host [37].
Normal skin flora varies around the body dependent
on moisture levels, body temperature and concentra-
tion of skin surface lipids [37]. Skin areas with partial
occlusion like toe webs, axilla and perineum often
harbour more microorganisms than less occluded
areas like the legs, arms and trunk [37]. Staphylo-
coccus epidermidis is a major skin inhabitant often
representing 90 % of resident aerobic flora [9].
Staphylococcus aureus is common, being present in 10
to 40 % of the adult population [37]. Other microor-
ganisms such as micrococci, diptheroids, peptostrep-
tococcus (anaerobic) and gram-negative bacilli also
contribute towards skin flora [37].
Local practice, after clinical diagnosis of infection, was
to collect a wound swab to identify microbiology causing
the infection, therefore (as data collection was retro-
spective) the taking of a wound swab was interpreted as
Table 1 Patients diagnosed with RA, had foot ulcers present in the study period and had swabs taken. [Swab group]
Study
Number
Agea in
years
Gender Disease Durationa
in years
Diabetes CTD CVD
/PVD
Smoker Y/
N
DAS:28 [within
4 weeks of
index swab]
Standard
DMARD
therapy
Anti – TNF
therapy
Other biologic
therapy
Steroid
therapy
1 82 F N/A N N Y Y current N/A N N N N
2 67 M 28 N N Y N N/A Y N Y Y
3 78 F 17 N N N N N/A Y N N N
4 85 M 26 Y N Y N N/A N N N N
5 67 M 15 N N Y N previous N/A Y N N Y
6 72 F 30 N N N N previous N/A Y N Y N
7 71 M 25 Y N Y N previous N/A Y N N N
8 76 F 13 N N Y Y current N/A Y N Y N
Mean:
74.75
F = 4 Mean: 22 Y = 2 Y =
0
Y = 6 N = 6 No scores
in notes.
N = 2 N = 8 N = 5 N = 6
Median:74 M = 4 Median:25 N = 6 N =
8
N =
2
Y = 2 Y = 6 Y = 0 Y = 3 Y = 2
CTD connective tissue disease, CVD/PVD cardiovascular / peripheral vascular disease, N/A indicates missing data; Y yes, N no; F female, M male
arelates to index swab date
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clinical infection, for the purpose of this study. Eight
of the 28 patients (28.5 %) with RA foot-ulcers had
swabs taken, presumably because the clinician diag-
nosed infection, this percentage of infection was lower
than the authors expected, but comparable to the inci-
dence of infection seen in diabetic foot ulcers (DFU)
in other studies [38]. The potential prevalence of
infection was possibly lower, as the microbiology
results suggest inaccurate diagnosis of infection. Fur-
ther study is clearly needed to describe the micro-
organisms found in infected foot-ulcers in RA, to
guide empiric therapy.
Ability of wound swabs to characterise the infection in
DFU has been questioned in the literature [35, 36]. Stud-
ies have suggested that deep tissue biopsy may be more
sensitive at detecting organisms and guiding subsequent
antibiotic therapy [35, 39]. It has also been suggested
that bacterial cultures inherently amplify the bacteria
that grow easily and are unable to fully identify the di-
versity of all microorganisms that may be present in a
wound [36]. Recently, the molecular method of real-time
polymerase chain reaction (PCR) has been proposed for
the identification of microorganisms with studies report-
ing greatly increased sensitivity when compared to trad-
itional cultures [40]. Rhoads et al. [40] hypothesise that
clinical outcomes for patients with chronic wounds
could improve if this was used to identify bacteria but
this is untested. Commonly cited indicators of infection
in DFU include increasing pain, erythema, oedema, heat
and purulent exudate, if used in combination they can
provide a moderately reliable predictive tool [38]. A sim-
ple classification system of DFU infection combined with
a vascular assessment has been shown to assist clinicians
to diagnose and manage DFU infection care [41]. The
validity of these indicators in an immunosuppressed
population of patients with RA remains unclear.
Although there are guidelines for screening the feet of
RA patients, which includes foot ulcers [42], there are
no standardised guidelines or classification systems for
diagnosing infection in the foot-ulcers of patients with
RA; those used in chronic wounds [9] are not validated
in this patient population. Consequently individual clini-
cian’s decisions are reliant on experience and the evi-
dence that supports diagnosing infection in other patient
groups, like DFU [38].
The clinicians in this area may have high sensitivity
and low specificity at identifying infection because of the
high risk of, and consequences of, infection during im-
munosuppressive therapy, such as DMARDs, steroids
and biologic therapies [43, 44]. With anti-TNF therapies
being linked to an increase in skin and soft tissue infec-
tions [14–16]. DMARDs are recommended for RA pa-
tients, providing relief from symptoms and prevention of
disease progression. The documented evidence, inform-
ing practitioners on safe use, recommends DMARDs are
suspended in the face of infection [42, 45]. Six of the
eight study patients were receiving these and 3 were re-
ceiving biologic therapies. If neutropenia develops as a
result of these therapies then the risk from normal skin
flora contributing towards the development of cellulitis
where there is a break in the skin, or ulceration is in-
creased. The risk of infection therefore may have led to
swabbing to rule out infection, the swab may have been
taken to reassure the clinician. However, clinical notes
were not detailed enough to inform the research team of
the clinicians reasoning behind swab collections.
The patients characteristics support the evidence that
increasing age and disease duration impact the risk of
developing foot-ulcers: However whether these also in-
crease the risk of developing infection requires further
study. Due to increasing age and decreasing dexterity,
typical for these patients, personal hygiene ability re-
quires consideration when evaluating risk.
Comorbidities of CVD/PVD are evident in a large pro-
portion of the study patients, supporting previous
Table 2 Comparison Group: RA patients with foot-ulcer but no
swabs taken during study period or in the year before first
attendance at the foot ulcer clinic
Agea in years Gender Disease Durationa in years
84 F 14
71 F 22
80 F 7
77 F 8
61 F 51
84 M 27
79 M 10
87 F 27
81 F 49
74 F 15
78 F N/A
67 M 18
82 F 62
44 M 1
73 M 32
72 F 20
75 F 21
73 M 36
73 F 4
50 F 20
Mean: 73.25 F = 14 Mean: 23.3
Median:74 M = 6 Median: 20
N/A indicates missing data, F female, M male
aIndicates at first clinic attendance during study period
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Table 3 Microbiology Information collected from the patients with RA, had foot ulcers present in the study period and had swabs taken [swab group]
Study
No.
Location of Ulcer Clinical Picture Microscopy Culture result Sensitivity
detected
Treatments/antibiotics used
1 Right 2nd toe Thick yellow pus type exudate coming from
original ulcer and on exit wound of lateral
border of apex. Same toe. Unable to probe
as very painful.
Skin flora ++ Non specified Co-Amoxiclav.
10 weeks prescribed but only completed
3 weeks due to side effects.
Swabs from before the index swab:
41 days before: scanty skin flora
39 days before: skin flora +X-ray 3 months before index swab showed osteomyelitis.
Antibiotics before index swab:
Bone removed 7 days after index swab for culture. 39 days before: Flucloxacillin
41 days before: nil antibiotics
2 Left medial malleolus. Granular spreading infection – lot of exudate and spreading to deep
tissue – probing more than 10 mm. X-ray taken.
Swab rejected from microbiology as no
location/no Consultant specified.
N/A Flucloxacillin
15 days before index swab: wound clean, a granular base with no
evidence of infection. 4 mm x 4 mm.
3 Plantar aspect of
right 1st toe, IP joint.
Index swab taken at start of ulcer. Mixed skin and enteric flora +++ Non specified Clarithromycin
Ulcer dressed by district nurse before referral to podiatry 107 days
later.
4 Right 3rd plantar, MTP
joint.
Foot ulcer swab. Skin flora ++ with anaerobe ++ Non specified Flucloxacillin
5 Left 4th IP joint. Probe depth to bone. No clinical signs of infection. Skin flora + with anaerobe + Metronidazole None listed.
6 Left 2nd and 3rd toes. Ulcer x2 middle toes left foot. Staphylococcus aureus +++. Flucloxacillin
sensitive
Flucloxacillin
Documented as: May represent
colonisation only. Suggest treat only
if current clinical evidence of infection.
Penicillin
Resistant
Clarith/Eryth
Sensitive.
7 Plantar lesion right
hallux. 1st MTP joint.
Deep ulcer under right hallux. Probing to bone.
Aspirated bursa fluid sent to microbiology.
Gram stain: no organisms seen Non specified None
Gram WBC: none seen
These samples are not routinely
examined for crystals.
Culture: no growth
8 Left big toe. Infected rheumatoid nodule. Skin flora ++ with anaerobe ++ Non specified None stated
May represent colonisation only.
Skin flora + with Anaerobe ++14 days after index swab: RA infected Left big toe Sensitive to
Metronidazole
Flucloxacillin
The patient study numbers correlate with those in Table 1
MTP metatarsophalangeal, IP interphalangeal, N/A not applicable
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research of an increased risk factor: However of the two
diabetic patients’ only one cultured skin flora with an-
aerobes [37].
Limitations of the study include incomplete and miss-
ing data, as original data (patients’ notes) were collected
during routine hospital appointments [46]. Furthermore
a cross-sectional study design does not allow for longer
term evaluation of the consequences of colonised skin
flora in foot-ulcers of the study patients. The small
population and single study site also limits reliability and
generalisability of the study. The retrospective data col-
lection used in the study meant the clinicians’ rationale
for taking a swab was not available to the authors. Con-
sequently this limits the interpretation of the primary
aim of the study, to identify the prevalence of clinical in-
fection in foot ulcers of RA patients.
Conclusion
Almost 30 % of patients with foot ulcers and RA had
swabs taken for wound infection (defined as clinical in-
fection). The majority of microbiology results did not
concur with the clinicians’ diagnosis of infection. The
study was unable to conclude possible relationships be-
tween the types of microorganisms identified in the foot
ulcers and previously identified risk factors for infection
in this patient group.
The rational for clinical judgements and decisions was
not available through retrospective data-collection, this
needs further investigation to understand.
The process of collecting specimens for identification
of colonised bacteria also needs further research to es-
tablish best practice and reliable methods.
However clinician diagnosed infection and cultured
evidence of infection are two different concepts and
clearer guidelines would inform the practitioner of when
it is safe to continue therapy and when it should be
with-held, so improving patient care.
More research is needed to investigate actual infection
rates of foot-ulcers in RA patients, providing practice
guidelines and standardisation of care.
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